-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Outperform on Eli Lilly, Raises Price Target to $1385

Benzinga·07/14/2026 14:39:02
Listen to the news
Bernstein analyst Courtney Breen maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $1300 to $1385.